In addition, it has a role as a biomarker for familial cancer risk assessment and cancer prognosis; MSI status was found to predict the response to immune checkpoint inhibitors such as the programmed cell death 1 (PD-1) inhibitor [127]. Here, PDCD1 is linked to cancer.